Abstract
SummaryEvidence is presented in rats that the liver is involved in clearance from the circulation of the coagulant intermediate, product I. Although product I injected into the general circulation failed to elicit the defibrination syndrome, similar injections accompanied by ligation of the hepatic blood supply were followed by a significant drop in plasma fibrinogen. Product I was largely inactivated following perfusion through the liver, but addition of antiheparin drugs to the perfusate prevented this inactivation. No anticoagulant activity could be demonstrated in perfused material. Perfusion through the liver of product I precursors demonstrated inactivation of factor IX but no effect on factors V, VII, VIII, or X.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
